326 related articles for article (PubMed ID: 19179966)
1. The association between upper gastrointestinal lesions and high-sensitivity C-reactive protein in coronary artery disease patients.
Fabijanić D; Banić M; Kardum D; Sutlić Z; Simunić M; Bonacin D; Romić Z; Petricusić L; Kujundzić M
Med Sci Monit; 2009 Feb; 15(2):CR45-50. PubMed ID: 19179966
[TBL] [Abstract][Full Text] [Related]
2. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
Gui MH; Hong J; Lü AK; Chen Y; Shen WF; Li XY; Ning G
Chin Med J (Engl); 2008 Dec; 121(24):2509-16. PubMed ID: 19187587
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein associated with coronary artery disease in Iranian patients with angiographically defined coronary artery disease.
Kazemi-Bajestani SM; Ghayour-Mobarhan M; Ebrahimi M; Moohebati M; Esmaeili HA; Ferns GA
Clin Lab; 2007; 53(1-2):49-56. PubMed ID: 17323825
[TBL] [Abstract][Full Text] [Related]
4. "Poor man's risk factor": correlation between high sensitivity C-reactive protein and socio-economic class in patients of acute coronary syndrome.
Sethi R; Puri A; Makhija A; Singhal A; Ahuja A; Mukerjee S; Dwivedi SK; Narain VS; Saran RK; Puri VK
Indian Heart J; 2008; 60(3):205-9. PubMed ID: 19240308
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
[TBL] [Abstract][Full Text] [Related]
6. [Predictive value of fibrinogen and high-sensitivity C-reaction protein for cardiovascular events in patients with stable coronary artery disease].
Huang W; Chen QW; Lei H; Deng W; Ke DZ
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Aug; 34(8):718-21. PubMed ID: 17081398
[TBL] [Abstract][Full Text] [Related]
7. Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; O'Donoghue M; Jablonksi KA; Rice MM; Solomon S; Rosenberg Y; Domanski MJ; Hsia J;
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2463-9. PubMed ID: 17766330
[TBL] [Abstract][Full Text] [Related]
8. Variability of C-reactive protein levels among patients with stable coronary artery disease and on statin therapy.
Blum A; Costello R; Samsel L; Zalos G; McCoy P; Csako G; Waclawiw MA; Cannon RO
Isr Med Assoc J; 2009 Oct; 11(10):602-5. PubMed ID: 20077946
[TBL] [Abstract][Full Text] [Related]
9. Plasma pyridoxal 5'-phosphate and high-sensitivity C-reactive protein are independently associated with an increased risk of coronary artery disease.
Cheng CH; Lin PT; Liaw YP; Ho CC; Tsai TP; Chou MC; Huang YC
Nutrition; 2008 Mar; 24(3):239-44. PubMed ID: 18312786
[TBL] [Abstract][Full Text] [Related]
10. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
[TBL] [Abstract][Full Text] [Related]
11. Association of C-reactive protein with body fat, diabetes and coronary artery disease in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-6).
Mohan V; Deepa R; Velmurugan K; Premalatha G
Diabet Med; 2005 Jul; 22(7):863-70. PubMed ID: 15975100
[TBL] [Abstract][Full Text] [Related]
12. Pre-operative high sensitive C-reactive protein predicts cardiovascular events after coronary artery bypass grafting surgery: a prospective observational study.
Balciunas M; Bagdonaite L; Samalavicius R; Griskevicius L; Vuylsteke A
Ann Card Anaesth; 2009; 12(2):127-32. PubMed ID: 19602737
[TBL] [Abstract][Full Text] [Related]
13. Plasma concentrations of C-reactive protein and total homocysteine in relation to the severity and risk factors for cerebrovascular disease.
Youssef MY; Mojiminiyi OA; Abdella NA
Transl Res; 2007 Sep; 150(3):158-63. PubMed ID: 17761368
[TBL] [Abstract][Full Text] [Related]
14. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D
Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
[TBL] [Abstract][Full Text] [Related]
15. Association between C-reactive protein and clinical outcomes in peritoneal dialysis patients.
Avram MM; Fein PA; Paluch MM; Schloth T; Chattopadhyay J
Adv Perit Dial; 2005; 21():154-8. PubMed ID: 16686309
[TBL] [Abstract][Full Text] [Related]
16. Correlation of exercise capacity with high-sensitive C-reactive protein in patients with stable coronary artery disease.
Rahimi K; Secknus MA; Adam M; Hayerizadeh BF; Fiedler M; Thiery J; Schuler G
Am Heart J; 2005 Dec; 150(6):1282-9. PubMed ID: 16338272
[TBL] [Abstract][Full Text] [Related]
17. The presence of metabolic syndrome is independently associated with elevated serum CD40 ligand and disease severity in patients with symptomatic coronary artery disease.
Lee WL; Lee WJ; Chen YT; Liu TJ; Liang KW; Ting CT; Huey-Herng Sheu W
Metabolism; 2006 Aug; 55(8):1029-34. PubMed ID: 16839837
[TBL] [Abstract][Full Text] [Related]
18. [Gastroduodenal mucosal lesions and coronary atherosclerosis severity in patients with coronary artery disease].
Banić M; Fabijanić D; Kardum D; Anić B; Sutlić Z; Romić Z; Petricusić L; Bonacin D; Kujundzić M
Lijec Vjesn; 2008; 130(9-10):228-33. PubMed ID: 19062758
[TBL] [Abstract][Full Text] [Related]
19. Relation of high-sensitivity C-reactive protein level with coronary vasospastic angina pectoris in patients without hemodynamically significant coronary artery disease.
Hung MJ; Cherng WJ; Yang NI; Cheng CW; Li LF
Am J Cardiol; 2005 Dec; 96(11):1484-90. PubMed ID: 16310426
[TBL] [Abstract][Full Text] [Related]
20. High-sensitivity C-reactive protein may be an indicator of the development of atherosclerosis in myocardial bridging.
Duygu H; Zoghi M; Nalbantgil S; Ozerkan F; Cakir C; Ertas F; Yuksek U; Akilli A; Akin M; Ergene O
Int J Cardiol; 2008 Feb; 124(2):267-70. PubMed ID: 17395309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
